FluoGuide
41,5 SEK +1,47%HC Andersen Capital on aikaisemmin saanut maksun yhtiöltä FluoGuide DigitalIR/Corporate Visibility -sopimuksesta. Tämä tarkoittaa, että sivulta voi löytyä maksettua materiaalia, jota ei ole päivitetty. Katso vastuuvapauslauseke.
FluoGuide is a Danish company active in medical technology. The company's business focus is found in research and development of treatments against various forms of cancer, with the greatest focus on the development of products that guide surgical interventions. The products bind to the cancer cells, which then light up and are intended to be used to precisely remove harmful tumors in the patient's tissue.
Viimeisimmät videot
Pörssikalenteri
Suurimmat omistajatLähde: Millistream Market Data AB
Omistaja | Osuus | Ääniä |
---|---|---|
Life Science IVS | 17,4 % | 17,4 % |
Wexotec ApS | 12,2 % | 12,2 % |
Inderes Premium
Tämä sisältö on vain Inderes Premium -käyttäjille.
FluoGuide intends to carry out a directed share issue of approximately SEK 60 million
Redeye: Fluoguide Q1 2024 - Preparing for next steps
Liity Inderesin yhteisöön
Älä jää mistään paitsi – luo käyttäjätunnus ja ota kaikki hyödyt irti Inderesin palvelusta.
FREE-tili
PREMIUM-tili
FluoGuide A/S publishes interim report for the period January – March 2024
FluoGuide selects laser system for photothermal cancer therapy with FG001
![Fluoguide: Wrap up from interview with CEO Morten Albrechtsen](https://www.inderes.se/cdn-cgi/image/format=auto,width=640,height=358,quality=90,fit=contain/https://content.inderes.se/assets/80e5ec49-e4de-4ab9-b18e-f9051fc68ce3.png)
Fluoguide: Wrap up from interview with CEO Morten Albrechtsen
Minutes from Annual General Meeting in FluoGuide A/S
![HCA Biosnack update: Biotech and Life Science stocks outperform as the general stock market moves to record highs.](https://www.inderes.se/cdn-cgi/image/format=auto,width=640,height=358,quality=90,fit=contain/https://content.inderes.se/assets/06aef4ac-f94b-407d-ac4d-dffe67b0f7a5.png)
HCA Biosnack update: Biotech and Life Science stocks outperform as the general stock market moves to record highs.
Chief Financial Officer (CFO) Ole Larsen buys shares
FluoGuide enters collaboration within robot assisted head and neck cancer surgery with Intuitive Surgical, a world leading robotic-assisted surgery company
![Fluoguide: Wrap up from introduction to the company](https://www.inderes.se/cdn-cgi/image/format=auto,width=640,height=358,quality=90,fit=contain/https://content.inderes.se/assets/4512dd49-f2aa-4490-981c-14b5bc354847.png)
Fluoguide: Wrap up from introduction to the company
Notice of Annual General Meeting in FluoGuide A/S
Redeye: Fluoguide Q4 2023 - Bright prospects
![Introduction to FluoGuide](https://www.inderes.se/cdn-cgi/image/format=auto,width=640,height=358,quality=90,fit=cover/https://content.inderes.se/assets/80e5ec49-e4de-4ab9-b18e-f9051fc68ce3.png)